Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg

NCT00565968 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

DRUG: melphalan
DRUG: sorafenib tosylate
GENETIC: gene expression analysis
GENETIC: protein expression analysis
GENETIC: western blotting
OTHER: pharmacological study

Sponsor

Duke University

Collaborators

[object Object]